Javitt Jonathan C

Track

Insider profile

Javitt Jonathan C's trades of NRX Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
403.37
Quantity 71,121 +1.5%
Value US$1,505,919
Transaction date
Purchase
Price
474.12
Quantity 9,142 -7.8%
Value US$2,658,161
Transaction date
Purchase
Price
423.29
Quantity 18,537 +6.9%
Value US$3,153,091
Transaction date
Purchase
Price
58.00
Quantity 100,000 +215.8%
Value US$5,800,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-18 2024-12-17
B Purchase
71,121 +1.5%
403.37
US$1,505,919 		71,121 +1.5% 403.37 US$1,505,919
2023-08-24 2023-08-23
B Purchase
9,142 -7.8%
474.12
US$2,658,161 		9,142 -7.8% 474.12 US$2,658,161
2023-08-23 2023-08-22
B Purchase
18,537 +6.9%
423.29
US$3,153,091 		18,537 +6.9% 423.29 US$3,153,091
2022-12-09 2022-12-07
S Sale
400,000 -3.0%
1.00
US$400,000 		400,000 -3.0% 1.00 US$400,000
2022-06-02 2022-06-01
B Purchase
100,000 +215.8%
58.00
US$5,800,000 		100,000 +215.8% 58.00 US$5,800,000